Liminal BioSciences Inc.（LMNL）· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。

FMP · LMNL · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income

Breakdown	2022-12	2021-12	2020-12	2019-12	2018-12
Revenue
Revenue	$0.40M	$0.64M	$3.32M	$4.90M	$47.37M
Cost of Revenue	$0.00M	$0.00M	$2.03M	$2.76M	$38.00M
Gross Profit	$0.40M	$0.64M	$1.28M	$2.14M	$9.37M
Gross Margin %(computed)	100.00%	100.00%	38.71%	43.66%	19.78%
Operating Expenses
R&D Expenses	$15.30M	$18.35M	$56.83M	$75.11M	$91.67M
G&A Expenses	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M
Total Operating Expenses	$33.16M	$50.27M	$95.38M	$120.40M	$123.20M
Operating Income	($32.98M)	($49.56M)	($94.27M)	($210.63M)	($113.54M)
Operating Margin %(computed)	—	—	—	—	-239.67%
Interest Income	$0.00M	$0.00M	$0.45M	$0.00M	$0.31M
Interest Expense	$1.08M	$6.33M	$8.72M	$14.06M	$22.37M
Income Before Tax	($29.44M)	($44.95M)	($122.34M)	($234.46M)	($257.92M)
Income Tax Expense	($0.53M)	$0.12M	($0.20M)	($0.24M)	($20.02M)
Net Income	($28.92M)	($45.06M)	($122.14M)	($234.22M)	($195.37M)
Net Margin %(computed)	—	—	—	—	-412.39%
Per Share & EBITDA
EPS (Basic)	$-341.80	$-532.66	$-1443.70	$-2768.61	$-2359.49
Wtd Avg Shares	0.08M	0.08M	0.08M	0.08M	0.08M
EBITDA	($31.86M)	($45.21M)	($105.17M)	($200.72M)	($108.08M)
EBITDA Margin %(computed)	—	—	—	—	-228.15%